XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Sep. 30, 2020
Current Assets:    
Cash and cash equivalents $ 62,177 $ 30,785
Available-for-sale securities 5,741 30,313
Accounts receivable, net of allowances of $118 and $130 as of June 30, 2021 and September 30, 2020, respectively 8,601 7,675
Contract assets — royalties and license fees 7,043 6,108
Inventories, net 6,316 5,966
Income tax receivable 1,136 2,391
Prepaids and other 3,098 3,370
Total Current Assets 94,112 86,608
Property and equipment, net 29,112 30,103
Available-for-sale securities 4,050  
Deferred income taxes 6,368 7,315
Intangible assets, net 11,482 13,283
Goodwill 27,379 27,185
Other assets 4,696 4,269
Total Assets 177,199 168,763
Current Liabilities:    
Accounts payable 1,519 1,515
Accrued liabilities:    
Compensation 6,689 6,630
Accrued other 4,303 5,547
Deferred revenue 5,151 5,200
Total Current Liabilities 17,662 18,892
Deferred revenue, less current portion 11,035 10,796
Other long-term liabilities 7,670 8,020
Total Liabilities 36,367 37,708
Commitments and Contingencies (Note 17)
Stockholders’ Equity:    
Series A Preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock — $.05 par value, 45,000 shares authorized; 13,872 and 13,672 shares issued and outstanding as of June 30, 2021 and September 30, 2020, respectively 694 684
Additional paid-in capital 20,025 15,369
Accumulated other comprehensive income 3,759 3,174
Retained earnings 116,354 111,828
Total Stockholders’ Equity 140,832 131,055
Total Liabilities and Stockholders’ Equity $ 177,199 $ 168,763